Related Experiment Video
Updated: Aug 16, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
Takashi Oshima1, Masahiro Abe, Jin Asano
1Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Abstract:
Multiple myeloma (MM) develops devastating bone destruction with enhanced bone resorption and suppressed bone formation. In contrast to enhanced osteoclastogenesis, little is known about the mechanism of impaired bone formation in MM. Because a canonical Wingless-type (Wnt) signaling pathway has recently been shown to play an important role in osteoblast differentiation, we examined whether MM cells affect a canonical Wnt pathway to suppress bone formation. Conditioned media from RPMI8226 and U266 MM cell lines and primary MM cells suppressed in vitro mineralization as well as alkaline phosphatase activity in osteoblasts induced by bone morphogenetic protein 2 (BMP-2). These cell lines constitutively produced a soluble Wnt inhibitor, secreted Frizzled-related protein 2 (sFRP-2), but not other Wnt inhibitors including sFRP-1, sFRP-3, and dickkopf 1 (DKK-1) at the protein level. Most MM cells from patients with advanced bone destructive lesions also expressed sFRP-2. Furthermore, exogenous sFRP-2 suppressed osteoblast differentiation induced by BMP-2, and immunodepletion of sFRP-2 significantly restored mineralized nodule formation in vitro, suggesting a predominant role for MM cell-derived sFRP-2 in the impairment of bone formation by MM. Thus, in addition to enhanced osteolysis, MM cells also suppress bone formation at least in part through an inhibition of the canonical Wnt pathway by secreting sFRP-2.
Insights
Multiple myeloma (MM) impairs bone formation by secreting a Wnt pathway inhibitor, secreted Frizzled-related protein 2 (sFRP-2). This finding reveals a new mechanism contributing to bone destruction in MM patients.
Area of Science:
- Bone Biology
- Cancer Biology
- Molecular Signaling
Background:
- Multiple myeloma (MM) causes significant bone destruction through increased resorption and reduced formation.
- The mechanisms underlying impaired bone formation in MM are not well understood.
- The canonical Wingless-type (Wnt) signaling pathway is crucial for osteoblast differentiation.
Purpose of the Study:
- To investigate whether MM cells interfere with the canonical Wnt pathway to suppress bone formation.
- To identify specific molecules involved in MM-induced suppression of bone formation.
Main Methods:
- Cultured MM cell lines (RPMI8226, U266) and primary MM cells.
- Used conditioned media to assess effects on osteoblast differentiation and mineralization.
- Measured alkaline phosphatase activity and mineralized nodule formation.
- Analyzed expression of Wnt inhibitors (sFRP-2, sFRP-1, sFRP-3, DKK-1).
- Administered exogenous sFRP-2 and performed immunodepletion experiments.
Main Results:
- Conditioned media from MM cells suppressed osteoblast mineralization and alkaline phosphatase activity.
- MM cell lines and patient MM cells predominantly produced secreted Frizzled-related protein 2 (sFRP-2).
- Exogenous sFRP-2 inhibited BMP-2-induced osteoblast differentiation.
- Depletion of sFRP-2 restored mineralized nodule formation, indicating its critical role.
Conclusions:
- MM cells suppress bone formation, at least partly, by inhibiting the canonical Wnt pathway.
- MM cell-derived sFRP-2 is a key factor in impairing osteoblast differentiation and bone formation.
- This study identifies sFRP-2 as a therapeutic target for MM-related bone disease.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Abnormal Proliferation
Osteoclasts in Bone Remodeling
Non-Canonical Wnt Signaling Pathways
